1.
Diagn Microbiol Infect Dis
; 90(2): 120-122, 2018 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29195768
RESUMO
Daptomycin ß-Lactam combination therapy offers "protection" against daptomycin non-susceptibility (DNS) development in Enterococcus faecium. We report failure of this strategy and the importance of source control. Mutations were detected in the LiaF and cls genes in DNS isolates. A single DNS isolate contained an unrecognized mutation, which requires confirmation.